(Q47812438)

5 February 2018

title

Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain (English)

1 reference

5 February 2018

0 references

1 reference

Chuan-hai Zhang

1

1 reference

5 February 2018

Jia-hai Lu

2

1 reference

5 February 2018

Yi-fei Wang

3

1 reference

5 February 2018

Huan-ying Zheng

4

1 reference

5 February 2018

Sheng Xiong

5

1 reference

5 February 2018

Mei-ying Zhang

6

1 reference

5 February 2018

Xin-jian Liu

7

1 reference

5 February 2018

Jiu-xiang Li

8

1 reference

5 February 2018

Zhuo-yue Wan

9

1 reference

5 February 2018

Xin-ge Yan

10

1 reference

5 February 2018

Shu-Yuan Qi

11

1 reference

5 February 2018

Zhiyong Cui

12

1 reference

5 February 2018

Biliang Zhang

13

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 May 2005

1 reference

5 February 2018

published in

Vaccine

1 reference

5 February 2018

volume

23

1 reference

5 February 2018

issue

24

1 reference

5 February 2018

page(s)

3196-3201

1 reference

5 February 2018

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Coronavirus as a possible cause of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

A novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

The Genome sequence of the SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

The global impact of vaccines containing aluminium adjuvants

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

7 January 2021

https://pubmed.ncbi.nlm.nih.gov/15837220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Preparation, characterization and preliminary in vivo studies of inactivated SARS-CoV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.073

Mechanism of action of CpG DNA.

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15837220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15837220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.073

1 reference

5 February 2018

PMC publication ID

7115646

0 references

1 reference

5 February 2018